SCHEMBL6173237

SCHEMBL6173237

[CH2]c1c(C)cncc1-c1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.45
CYP11B2 P19099 3/20 0.45
PTGS2 P35354 3/20 0.45
KMT2A Q03164 3/20 0.44
MAPT P10636 1/20 0.42
RPS6KA3 P51812 1/20 0.41
QPCT Q16769 1/20 0.41
QPCTL Q9NXS2 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
ABL1 P00519 1/20 0.40
ABCB1 P08183 1/20 0.40
BCR P11274 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21803770 0.75 CYP11B1 (0.55) CYP11B1CYP11B2PTGS2KMT2AMAPT
SCHEMBL1679541 0.72 PTGS2 (0.45) CYP11B1CYP11B2PTGS2KMT2AMAPT
SCHEMBL1679164 0.69 ERN1 (0.42) CYP11B1CYP11B2PTGS2KMT2AMAPT
SCHEMBL12615725 0.68 CYP11B1 (0.54) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL4214556 0.68 CYP11B1 (0.78) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL29501832 0.68 CYP11B1 (0.78) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL1891962 0.68 MAPT (0.49) CYP11B1CYP11B2PTGS2KMT2AMAPT
SCHEMBL29501870 0.68 CYP11B1 (0.68) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL6739910 0.67
Hydrochloric Acid SCHEMBL8503236 0.67 CYP11B1 (0.76) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed